The United States Hispanic Chamber of Commerce (USHCC) welcomes Boehringer Ingelheim Pharmaceuticals – among the world’s top pharmaceutical companies — to its family of corporate members, as a strategic partner.
Boehringer Ingelheim's commitment to educating the Hispanic community on the impact of chronic disease is particularly noteworthy. Their dedication to community health was highlighted during last year's launch of a highly successful initiative, in partnership with Univision, that promoted best practices for preventing and treating diabetes. The company seeks to further advance these efforts through its partnership with the USHCC, working with small business owners to encourage healthy living for the benefit of these small firms and their employees.
"The USHCC is proud to welcome an industry leader like Boehringer Ingelheim into our association. Together, we will implement programs that raise awareness of how chronic diseases like diabetes have a negative effect on the productivity and viability of small businesses, and have a deep impact in the Hispanic community as a whole," said USHCC President & CEO Javier Palomarez.
Since its founding in 1885, Boehringer Ingelheim has focused on manufacturing and marketing products that address various illnesses, including respiratory disease, cardiovascular disease, diabetes and hepatitis – all of which are prevalent within the Hispanic community. Today, BIPI is focused on the future, with a new corporate vision based on value through innovation and medical solutions that help address our world’s greater social and economic challenges.